Last reviewed · How we verify

Seroquel — Competitive Intelligence Brief

Seroquel (Seroquel) competitive landscape: 4 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Neuroscience.

marketed Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A Neuroscience Small molecule Live · refreshed every 30 min

Target snapshot

Seroquel (Seroquel) — University of Pittsburgh.

Comparator set (4 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Seroquel TARGET Seroquel University of Pittsburgh marketed Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A
Zyprexa Zyprexa Washington University School of Medicine marketed Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A
Seroquel quetiapine AstraZeneca marketed Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A
Zyprexa olanzapine Eli Lilly marketed Atypical Antipsychotic [EPC] Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A
Quetiapin Quetiapin Sykehuset Innlandet HF marketed Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Seroquel — Competitive Intelligence Brief. https://druglandscape.com/ci/seroquel. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: